Details of the Drug

General Information of Drug (ID: DMB867J)

Drug Name

CC100

Indication

Disease Entry	ICD 11	Status	REF
Amyotrophic lateral sclerosis	8B60.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03049046) CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS (CC100B). U.S. National Institutes of Health.